DENALI THERAPEUTICS INC's ticker is DNLI and the CUSIP is 24823R105. A total of 186 filers reported holding DENALI THERAPEUTICS INC in Q2 2022. The put-call ratio across all filers is 0.37 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $1,437,375 | -30.1% | 69,674 | -0.0% | 0.00% | -25.0% |
| Q2 2023 | $2,054,923 | +33.2% | 69,678 | +4.0% | 0.00% | 0.0% |
| Q1 2023 | $1,543,173 | +1.6% | 66,978 | +22.7% | 0.00% | 0.0% |
| Q4 2022 | $1,518,621 | +1.2% | 54,607 | +11.7% | 0.00% | 0.0% |
| Q3 2022 | $1,500,000 | +44.6% | 48,898 | +38.8% | 0.00% | +33.3% |
| Q2 2022 | $1,037,000 | +192.9% | 35,234 | +402.1% | 0.00% | +200.0% |
| Q3 2021 | $354,000 | -23.0% | 7,017 | +19.8% | 0.00% | 0.0% |
| Q2 2021 | $460,000 | – | 5,856 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Crestline Management, LP | 7,705,039 | $343,645,000 | 25.68% |
| Casdin Capital, LLC | 1,500,000 | $66,900,000 | 1.89% |
| Flagship Pioneering Inc. | 2,619,968 | $116,851,000 | 1.81% |
| SECTORAL ASSET MANAGEMENT INC | 189,600 | $8,456,000 | 1.27% |
| Integral Health Asset Management, LLC | 100,000 | $4,460,000 | 1.23% |
| Temasek Holdings (Private) Ltd | 5,369,487 | $239,479,000 | 0.86% |
| Goldstream Capital Management Ltd | 78,418 | $3,497,000 | 0.86% |
| Yiheng Capital Management, L.P. | 335,184 | $14,949,000 | 0.76% |
| GILDER GAGNON HOWE & CO LLC | 2,900,114 | $129,345,000 | 0.74% |
| Artal Group S.A. | 600,000 | $26,760,000 | 0.73% |